Arachidonic Acid Market (2026 - 2033)

Arachidonic Acid Market Summary

The global arachidonic acid market size was valued at USD 243.9 million in 2025 and is projected to grow from USD 254.1 million in 2026 to USD 370.1 million by 2033, at a CAGR of 5.5% from 2026 to 2033. North America market dominated, with a revenue share of 30.7% in 2025. ARA is a fatty acid that supports the development of an infant’s brain.

Source: Grand View Research, IR Documents, Primary Interviews, Paid Databases

To learn more about this report, Download Free Sample Report

The growing consumer awareness related to baby care products is driving the industry's growth. Moreover, increasing product demand to heal critical physical injuries is likely to support the growth. It helps in improving visual acuity, balances phosphate, and calcium levels, enhances neuron growth, and promotes cell survival in developing infants. The key product manufacturers are focusing on improving the in-house manufacturing techniques and R&D activities to enhance product quality and brand value. A rise in population, income, awareness, and development of innovative technologies is resulting in a reduction in the production cost of ARA. This is also likely to trigger industry growth in the coming years.

To learn more about this report, Download Free Sample Report

Arachidonic acid is one of the essential acids in the Omega-6 group. It is considered an essential acid because it is stored inside the cell membranes and directs signals of adaptive changes in the damage events. The deficiency of natural arachidonic acid in the body necessitates a separate intake of it in the form of injections, syrups, or tablets. The major raw materials used for the production of ARA comprise corn, glucose, soy, and yeast among others.

The key producers are engaged in product synthesis by altering mortierella alpine (M.alpine), which is the most proficient manufacturing process. There is an increasing preference among end-users to buy arachidonic acid directly from suppliers instead of producers owing to the ability of the former to offer the product in large volumes, which further results in reduced prices. The production plants are located near the end-users to lower transportation costs, procure local incentives, and minimize the exposure to currency fluctuations. The companies involved in the production of infant formula are making constant efforts to improve consumer awareness via several educational campaigns. All these factors are expected to contribute to the overall industry growth.

Market Dynamics

The arachidonic acid (ARA) market is witnessing steady growth, driven by increasing demand for infant nutrition, dietary supplements, pharmaceuticals, and functional food products. Arachidonic acid (ARA), an essential omega-6 long-chain polyunsaturated fatty acid, plays a vital role in infant brain development, immune function, and cellular growth. Rising awareness of early-life nutrition, increasing birth rates in developing economies, and growing demand for fortified infant formula are supporting market expansion. Advancements in microbial fermentation technology and increasing investments in sustainable bio-based ingredient production are contributing to the long-term growth of the arachidonic acid (ARA) market.

Analyst Perspective

The global arachidonic acid market is positioned for steady growth, driven by increasing demand for infant nutrition, dietary supplements, pharmaceuticals, and functional food products. Arachidonic acid (ARA) is an essential omega-6 long-chain polyunsaturated fatty acid that plays a critical role in brain development, visual function, immune health, and cellular growth. The infant formula segment remains the largest application area, supported by the widespread inclusion of ARA alongside DHA to promote healthy cognitive and retinal development in infants. Rising consumer awareness of preventive healthcare, growing demand for premium nutritional ingredients, advancements in microbial fermentation technologies, and expanding applications in nutraceuticals and medical nutrition continue to support the long-term growth of the arachidonic acid (ARA) market.

 

Form Insights

Based on forms, the global industry has been further categorized into solid and solvent. Solvent segment dominated the product segment with a market share of 80.0% in 2025. The high share of this segment can be attributed to the increased product use in infant formula and supplements globally. The prominent industry players are involved in the development of advanced solvent-based products as it has higher profit margins. Increasing application in sports supplements drives the product demand in this segment. There is a shift in the consumer preference towards ARA-induced supplements, thus, positively impacting the industry growth.

The rising spending costs on sports nutrition are further expected to boost product demand. Companies are involved in the production of nutritional products, which comply with global standards and help in the overall market development. The solvent form helps in maintaining the fluidity of the cell membrane. It also helps in treating brain diseases and depression by increasing the dopamine levels in an individual. Furthermore, prominent companies in the industry are focusing on the development of advanced products to improve their portfolio and increase their profit margins.

Source Insights

Based on sources, the global industry has been further categorized into animal and plant. Plant segment projected the largest share of 53.1% in 2025 of the overall revenue. The high share of this segment can be attributed to the growing consumer demand for vegetarian or vegan products. It is also believed that a vegetarian diet can be beneficial for a patient suffering from chronic diseases. Seaweed is a prominent plant-based source of arachidonic acid.

Vegetarians and vegans can get ARA via linoleic acid. This acid can be easily found in nuts seeds, legumes, and grains. It helps in improving the immune, nervous, and skeletal systems of an individual. The growing consumer preference for natural products is driving the demand for plant-based ARA across the globe. The animal-based ARA is found in large quantities owing to its presence in various poultry animals, meat, eggs, and seafood among others. A single egg can even elevate the levels of arachidonic acid in the bloodstream of a human. In addition, the easy availability of animal sources is positively impacting its demand.

Application Insights

Infant formula held the largest share of 82.1% in 2025. Its high share is attributable to the increasing awareness concerning the benefits of ARA in infant brain development and rising spending on infant nutrition. In addition, the growing regulatory acceptance for oil-based ARA products in infant nutrition is positively impacting the demand.ARA is used to enhance a baby’s memory and eyesight. ARA-based supplements help in improving neural stem cell proliferation, which aids in the improvement of cognitive function among infants as well as adults. The growing consumer awareness related to the benefits of ARA in baby nutrition is projected to boost growth over the forecast period.

To learn more about this report, Download Free Sample Report

The daily consumption of ARA supplements has increased, especially among young individuals, as it helps in improving overall well-being and health. It works as an essential dietary part in the process of muscle hypertrophy owing to its ability to effectively repair skeletal muscle tissues. Furthermore, it also helps in increasing the overall body mass of an individual, in turn, making the person look more toned and fit. ARA contains muscle inflammation properties that result in speeding up the muscle gain process. The manufacturers are focusing on R&D for the development of new product applications, such as bodybuilding supplements and sports drinks.  The growing demand for health supplements, especially in urban areas across regions is expected to create lucrative opportunities for industry growth.

Regional Insights

North America accounted for 30.7% of the arachidonic acid market revenue in 2025, making it the largest regional market. U.S. held the highest market revenue share in North America in 2025. This is attributed to the presence of prominent companies in North America. The region is projected to expand further during the forecast years on account of the developed infant and sports nutrition industry, particularly in the U.S., and the high spending capacity of consumers. Europe is growing at a significant rate due to the early adoption of ARA in supplements and infant formula. The rising application of omega-6fatty acids in dietary supplements along with the favorable government regulations is positively impacting the demand.

To learn more about this report, Download Free Sample Report

Furthermore, factors, such as a well-developed sports nutrition market and a rising standard of living, are driving the regional industry. Asia Pacific is also expected to register a strong CAGR from 2025 to 2033 due to the emerging middle-class population, projected growth in the number of infants, and rapid urbanization across the region. The presence of emerging economies, such as India and China, and the availability of affordable raw materials and labor are influencing global manufacturers to expand their operations in the Asia Pacific region.

Key Companies & Market Share Insights

The industry is growing at a significant rate owing to the rising consumption in various end-use applications including supplements and infant formula. Outsourcing of manufacturing capabilities is expected to be the dominant trend in the market. Abbott Nutrition, Nestlé S.A., and Mead Johnson, prominent producers of infant formula and dietary supplements are some of the key end-users of the product. Some of the prominent players in the global arachidonic acid market include:

Key Arachidonic Acid Companies

The following key companies have been profiled for this study on the arachidonic acid market.

• Suntory Beverage & Food Ltd.

• Cayman Chemical Company

• Cargill, Inc.

• BASF SE

• CABIO Biotech (Wuhan) Co., Ltd.

• Guangdong Runke Bioengineering Co. Ltd.

• Koninklijke DSM N.V.

• Avanti Polar Lipids, Inc.

• Bio-Techne Corporation

• Merck KgaA

• A&Z Food Additives Co. Ltd.

Global Arachidonic Acid Market Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global arachidonic acid market report based on form, source, application, and region:

To learn more about this report, Download Free Sample Report

• Form Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)

  • Solid

  • Solvent

• Source Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)

  • Animal

  • Plant

• Application Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)

  • Infant Formula

  • Supplements

• Regional Outlook (Volume, Tons; Revenue, USD Million, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • China

    • India

    • Japan

  • Central & South America

    • Brazil

    • Argentina

  • Middle East & Africa

    • Saudi Arabia

    • South Africa

Research Methodology

The arachidonic acid market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each arachidonic acid segment quantified using the revenue-capture definitions in the table below.

Delivered Customizations

This report has been delivered with the following In-depth customizations